HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in ratsQie Shi, Erfan Wei, Xiaolei Song et al.|Neuroscience|2015Cited by 62
A nonalcoholic fatty liver disease cirrhosis model in gerbil: the dynamic relationship between hepatic lipid metabolism and cirrhosis.Li Wei, Xiaofeng Chu, Zheng Guan et al.|PubMed|2018Cited by 6